Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BioXcel Gross Margin

The Gross Margin of BioXcel Therapeutics Inc (BTAI) is 5.43%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

BioXcel Gross Margin - Historical Value
Date Value
2024-12-31 5.43%
2023-12-31 8.70%
2022-12-31 94.74%
BioXcel Gross Margin - Peers Comparison